Eliem Therapeutics logo

Eliem Therapeutics

ELYM | NASDAQ
Chart Builder DCF Calculator
$5.11
-$0.05 (-0.97%)
At close: Oct 02, 2024, 04:00 PM ET
-0.97%

Rating

Updated: Sep 25, 2026
27
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $342.68M
1D Range
5.00 5.26
52W Range
2.35 11.55

Valuation (TTM)

PE -6.23
PB 1.43
EV/EBITDA -33.97

Valuation (NTM)

Forward PE N/A
Forward PEG -0.55
Price Target N/A
Loading financial charts...

Profile

Eliem Therapeutics, Inc. is a clinical-stage biotechnology firm focused on developing therapeutic solutions for conditions characterized by abnormal neuronal excitability. The company aims to fulfill ...

Sector Healthcare
Industry Biotechnology
Employees 9
IPO Date Aug 10, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.